Coronavirus disease 2019 (COVID-19) is an infectious disease first diagnosed in December 2019. Regarding previous studies that indicated the potential association between preeclampsia (PE) and COVID-19, it is pertinent to assess these conditions’ clinical manifestations and laboratory findings comprehensively. We performed this narrative review, considering the importance of pregnancy and its maternal and fetal outcomes and the lack of a definite mechanism of COVID-19 in pregnant women with PE. It is noteworthy that both conditions may have overlapped characteristics that may affect the outcomes during pregnancy.
Implication for health policy/practice/research/medical education:
Regarding the outbreak of coronavirus disease 2019 (COVID-19), analysis of the interrelationship between the clinical manifestations and laboratory findings of preeclampsia and COVID-19 would be necessary.
Please cite this paper as: Hassanzadeh Rad A, Chatrnour G, Ghazanfar Tehran S, Fakhre Yaseri A. The association between preeclampsia and COVID-19; a narrative review on recent findings. J Renal Inj Prev. 2022; 11(4): e32061. doi: 10.34172/ jrip.2022.32061.